HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mary Kay Elige global prestige women's scent expected to outperform Journey.

This article was originally published in The Rose Sheet

Executive Summary

MARY KAY's ELIGE MARKS SECOND UPSCALE, GLOBAL LAUNCH for the Dallas-based direct sales company; the "indulgent, sophisticated" women's fragrance will roll out in September to 18 of the firm's 27 international markets, including the U.S., Mexico, Canada, Australia, Japan, China, Taiwan, New Zealand and a number of European countries. A launch in Brazil will follow in the spring of 1999. Elige, Mary Kay's second prestige scent to launch worldwide, follows Journey, which debuted last August ("The Rose Sheet" April 7, 1997, p. 4).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel